media – Page 608 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

Overuse of Multivitamins could be Harmful

Usage of multivitamins either through prescription or on own accord possibly crossed a limit in the past few years. New research published in Journal of American College of Cardiology reveals that health supplements can increase the risk of heart issues.
- Source: India Times
- 1,535
- June 26, 2018
Researches vitamin
Call for HIMSS19 Global Conference Speaker Proposals

There will be a total of twenty-four education categories/topics, which includes five new topics namely consumerization of health, grand societal challenges, healthy aging and technology, population and public health management as well as supply chain management.
- Source: MobiHealthNews
- 769
- June 26, 2018
Company Insight digital health health IT HIMSS
FDA Anounces Restricted use of Keytruda & Tecentriq Against Bladder Cancer

Keytruda is now allowed only for the patients whose tumor expression levels of the biomarker PD-L1 meet a combined positive score of 10 or higher. Tecentriq can only be used where PD-L1 immune cells can cover only 5% or more of their tumor area.
- Source: FiercePharma
- 883
- June 26, 2018
bladder cancer Company Insights Merck Roche
Nanobiotix NBTXR3 in Late Phase Clinical Trial

NBTXR3 is composed of crystalline nanoparticles to amplify the efficacy of radiation therapy. The idea is to administer NBTXR3 as intra-tumoral injections before external beam radiation therapy, thereby increasing the antitumor effect, and thus preparing the patient for surgical resection.
- Source: FierceBiotech
- 697
- June 26, 2018
cancer Clinical Trials radiation therapy
AstraZeneca’s Durvalumab Receives Go-Ahead from DCGI to Market in India

Last Friday, pharma giant AstraZeneca announced that it had received the go-ahead from the Drug Controller General of India (DCGI) to import and market durvalumab (ImfinziTM) in India. The receipt of this permission paves the way for the launch of durvalumab (ImfinziTM) in India. Durvalumab which is a patented drug of Astra-Zeneca, received permission in India to provide treatment for patients with unresectable non-small cell lung cancer and metastatic urothelial carcinoma.
- Source: United News of India
- 2,675
- June 26, 2018
AstraZeneca cancer India New Approvals
India’s First Future Health Index Launched by Philips

Key findings of the FHI 2018 allude to the lack of access on account of low skilled physician density and a low number of hospital beds. The study also highlighted the fact that semi-urban and rural areas are yet to leverage the advancements of digital healthcare. It also stated that healthcare professionals in the country were open to the deployment of futuristic technology such as AI and virtual reality in healthcare as compared to the general population.
- Source: Economic times
- 766
- June 25, 2018
Future Health Index India Market Views Phillips
Autolus Raises Impressive $150 Million for T-cell Therapy

The IPO has provided the biotech major with the financial bandwidth to aggressively pursue its new generation of CAR-T variants on a broader level, with the advancement of several therapies or the start of clinical trials over the next couple of months.
- Source: FierceBiotech
- 698
- June 25, 2018
acquisition cancer CAR-T therapies Company Insight
Cotiviti Holdings Acquired by Verscend Technologies for $4.9 Billion

The new business with unique data-driven capabilities will work as a private healthcare IT company with a big impact in the health sector by reducing waste and improving quality outcomes and affordability as well as offering opportunities to create substantial value for clients.
- Source: Healthcare Global
- 889
- June 25, 2018
Company Insight health IT
What to know about Thyroid Issues

Hypothyroidism is a condition where the thyroid gland is underactive meaning that it does not produce a sufficient amount of thyroid hormones. A common cause of hypothyroidism is Hashimoto’s thyroiditis, an autoimmune disease where the body produces antibodies which attack the thyroid.
- Source: WebMD
- 684
- June 25, 2018
health tips Researches thyroid
Good News for Medical Start-Ups

With the aid of scholarship-funded programs and start-up accelerators, many health start-ups have progressed and attained profitability. Now there is good news for small start-ups who seek funding to solve ongoing global medical issues. RebelBio’s start-up acceleration program offers up to £200K twice every year for life sciences start-ups to carry out scientific works.
- Source: Biotecnika
- 749
- June 25, 2018
Market Views start ups

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.